Dr. Kazem Kazempour

Biotech Insights From 45 Years Inside the World of Drug Development

Welcome to a blog where biotech finally makes sense. Dr. Kazem Kazempour shares lessons from nearly five decades in clinical research, the FDA, and drug development. Expect plain-English guides on clinical trials, biostatistics, and the FDA approval process. Start with our latest posts and see how science becomes medicine.

Who Is It For?

This blog is for anyone who wants the real story behind modern medicine. If you're a student breaking into clinical research or biostatistics, you'll find honest career maps and mentor-style guidance. If you're building a biotech startup or leading a pharma team, you'll get practical help with clinical trial design and the FDA approval process. If you're a working clinician, project manager, or statistician, you'll pick up tips you can use in your very next study. And if you're simply curious, you'll finally understand how a lab discovery becomes a medicine on the shelf. No jargon. No gatekeeping. Just knowledge that helps you move forward.

Dr. Kazem Kazempour

Dr. Kazem Kazempour has spent nearly five decades turning data into medicine. He began as a statistician in 1975 and joined the FDA as a statistical reviewer in 1991. There, he analyzed early HIV/AIDS trials and earned multiple FDA awards. In 1998, he co-founded a global contract research organization that helps bring new drugs and devices to patients. He has shaped more than 100 clinical trials, from HIV/AIDS to vaccines to cancer. Today, he teaches at George Washington University and writes here to share it all in plain English.

LEARN ABOUT DR. KAZEM KAZEMPOUR

Dr. Kazempour’s journey spans a genetics lab in Iran, the halls of the FDA, and the founding of a global clinical research company. Along the way, he earned multiple FDA awards and helped shape how clinical trials are run worldwide. Want the full story — and what still drives him today? Visit the About page →

FIND OUT MORE ABOUT THE BIO TECH

Ever wondered how a drug earns FDA approval, or why trial design can make or break a study? This blog digs into clinical trial design, biostatistics, regulatory strategy, and the rise of AI in medicine. Dive into our latest biotech insights and see how science becomes medicine.

Dr. Kazem Kazempour Bio Tech Blog

Hello and Welcome

Welcome to theDr. Kazem Kazempour Bio Tech Blog Archives. Here you will find information about Bio Tech Blog to increase your knowledge.

October 6, 2026

Dr. Kazem Kazempour Bio Tech Blog

Dr. Kazem Kazempour Bio Tech exists to make clinical research and biotech clear for everyone. Every post distills decades of drug development experience into lessons you can actually use. Subscribe, come back often, or reach out — the conversation is always open.

Hours

Monday - Friday: 9:00-5:30

We are here

Gaithersburg, Maryland